Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC) remains the most common form of liver cancer, accounting
for 90% of all primary liver cancers. Up to 30% of HCC cases could be small (2–3 cm in …

Background Recently introduced no-touch radiofrequency ablation (RFA) of hepatocellular
carcinoma (HCC) has the potential to improve local tumor control. Purpose To evaluate …

Background & Aims Radiofrequency ablation (RFA) and ablative external beam
radiotherapy (ablative RT) are commonly used to treat small intrahepatic malignancies. We …

Objective This study aimed to compare the efficacy between no-touch (NT) radiofrequency
ablation (RFA) and conventional RFA using twin internally cooled wet (TICW) electrodes in …

Simple Summary Percutaneous interventional radiological techniques offer many
alternatives for treatment of Hepatocellular Carcinoma (HCC) using local anesthesia and …

Although hepatocellular carcinoma (HCC) is associated with a poor prognosis, management
of early-stage HCC is often successful with highly efficacious treatment modalities such as …

Hepatocellular carcinoma (HCC) is the most common cause of liver malignancy and the
fourth leading cause of cancer deaths universally. Cure can be achieved for early stage …

Tumor ablation has been widely applied in Asia, accounting for 44.65% of clinical studies
worldwide. We reviewed 5853 clinical studies to provide insight on the advance of tumor …

BACKGROUND A wide range of ablative and non-surgical therapies are available for
treating small hepatocellular carcinoma in patients with very early or early-stage disease …